ATE108480T1 - Ws-9326 a, ws-9326b und deren derivate. - Google Patents

Ws-9326 a, ws-9326b und deren derivate.

Info

Publication number
ATE108480T1
ATE108480T1 AT89101607T AT89101607T ATE108480T1 AT E108480 T1 ATE108480 T1 AT E108480T1 AT 89101607 T AT89101607 T AT 89101607T AT 89101607 T AT89101607 T AT 89101607T AT E108480 T1 ATE108480 T1 AT E108480T1
Authority
AT
Austria
Prior art keywords
compounds
relates
derivatives
streptomyces
microorgnism
Prior art date
Application number
AT89101607T
Other languages
English (en)
Inventor
Tohru Kino
Motoaki Nishikawa
Masami Ezaki
Sumio Kiyoto
Masakuni Okuhara
Shigehiro Takase
Satoshi Okada
Nobuharu Shigematsu
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE108480T1 publication Critical patent/ATE108480T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
AT89101607T 1988-02-02 1989-01-31 Ws-9326 a, ws-9326b und deren derivate. ATE108480T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888802229A GB8802229D0 (en) 1988-02-02 1988-02-02 Ws-9326 & its derivatives

Publications (1)

Publication Number Publication Date
ATE108480T1 true ATE108480T1 (de) 1994-07-15

Family

ID=10630888

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89101607T ATE108480T1 (de) 1988-02-02 1989-01-31 Ws-9326 a, ws-9326b und deren derivate.

Country Status (9)

Country Link
EP (1) EP0327009B1 (de)
JP (1) JPH0676425B2 (de)
KR (1) KR970009151B1 (de)
AT (1) ATE108480T1 (de)
CA (1) CA1338261C (de)
DE (1) DE68916659T2 (de)
ES (1) ES2056967T3 (de)
GB (1) GB8802229D0 (de)
IE (1) IE64227B1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8807921D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives
IE64214B1 (en) * 1989-06-06 1995-07-26 Fujisawa Pharmaceutical Co Macrolides for the treatment of reversible obstructive airways diseases
US5830854A (en) * 1992-12-14 1998-11-03 Merck Sharp & Dohme, Limited Method of treating cystic fibrosis using a tachykinin receptor antagonist
EP2117538A1 (de) 2007-01-24 2009-11-18 Glaxo Group Limited Pharmazeutische zusammensetzungen mit 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
US9446029B2 (en) 2010-07-27 2016-09-20 Colorado State University Research Foundation Use of NK-1 receptor antagonists in management of visceral pain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1302926C (en) * 1986-03-04 1992-06-09 Hideo Sugawara Antibiotic f-0769, process for its production, and its use as a growthaccelerating and feed efficiency increasing agent and as an antitumour agent

Also Published As

Publication number Publication date
ES2056967T3 (es) 1994-10-16
EP0327009A1 (de) 1989-08-09
EP0327009B1 (de) 1994-07-13
GB8802229D0 (en) 1988-03-02
KR970009151B1 (ko) 1997-06-07
CA1338261C (en) 1996-04-23
IE890208L (en) 1989-08-02
KR890013191A (ko) 1989-09-21
JPH01304888A (ja) 1989-12-08
DE68916659D1 (de) 1994-08-18
IE64227B1 (en) 1995-07-26
JPH0676425B2 (ja) 1994-09-28
DE68916659T2 (de) 1994-11-17

Similar Documents

Publication Publication Date Title
KR920703597A (ko) 항종양성 물질 be-13793c
KR890002214A (ko) 데만노실 테이코플라닌 유도체
FI102547B1 (fi) Menetelmä valmistaa farmakologisesti käyttökelpoista peptidiyhdistettä
DE68916659T2 (de) WS-9326 A, WS-9326B und deren Derivate.
US4578383A (en) CL 1565 antibiotic compounds
KR890005139A (ko) 테이코플라닌 유사 유도체
NO901160D0 (no) Fremgangsmaate for fremstilling av ws 7622a, b, c og d stoffer og derivater derav.
HUT46945A (en) Process for producing new azoxy derivatives and pharmaceutical compositions containing them as active components
ES2080068T3 (es) Derivados de 2-piranona y su procedimiento de preparacion.
EP0468504A1 (de) Antibiotikum Balmimycin, dessen Verfahren zur Herstellung und dessen Verwendung als Arznei
ATE62248T1 (de) Ein doxorubicinderivat, ein verfahren zu dessen herstellung, pharmazeutische zusammensetzungen und dessen verwendung fuer die herstellung von arzneimitteln.
JP3530563B2 (ja) Ko−8119物質及びその製造法
DK0413967T3 (da) Antibiotikum
KR860002574A (ko) 항생물질 at 2433 복합체의 제조방법
EP0333177A3 (de) Verbindung FR-900493, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzung
JPS6456680A (en) Antibiotic substance 6270b
KR930006039A (ko) 화합물 ll-e19020 제타 및 화합물 ll-e19020 에타, 그들의 생산방법, 및 그를 포함하는 제약학적 항생물질 조성물